Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Streptococcus acidominimus causing invasive disease in humans: a case series

Contributed equally
Journal of Medical Case Reports20148:57

https://doi.org/10.1186/1752-1947-8-57

Received: 14 February 2013

Accepted: 9 December 2013

Published: 17 February 2014

Abstract

Introduction

Streptococcus acidominimus is a member of the viridans group streptococci and is rarely pathogenic in humans, making it difficult to assess its epidemiologic and clinical significance.

Case presentation

We report the cases of five Han Chinese patients with invasive diseases caused by S. acidominimus over a one-year time frame. Three of the patients developed continuous fever after surgery, consisting of a successful elective laparoscopic cholecystectomy (case 1), a laparoscopic esophageal resection and gastroesophageal anastomosis (case 2), and a liver transplant in a patient with liver cancer (case 3). For these three patients, cultures of the purulent drainage material grew S. acidominimus. Case 4 concerns a 52-year-old man who developed sepsis 48 hours after hospitalization for hepatitis, liver cirrhosis and hepatitis-related glomerulonephritis. Case 5 concerns a 55-year-old woman receiving regular hemodialysis who had low-grade fever for one month. For these two patients, blood cultures grew S. acidominimus. An antimicrobial susceptibility test revealed that S. acidominimus was resistant to clindamycin and, to some degree, beta-lactam or macrolides. The S. acidominimus from the patient on hemodialysis was resistant to multiple antibiotics.

Conclusion

S. acidominimus is an ever-increasing cause of disease, especially in patients who are critically ill. It is showing increased resistance to antimicrobial agents, so in patients with viridans group streptococci infections, it is necessary to identify the species to improve the clinical management of S. acidominimus.

Keywords

Case series Streptococcus acidominimus Viridans group streptococci

Introduction

Streptococcus acidominimus is a member of viridans group streptococci (VGS) [1]. Generally, S. acidominimus is considered to be a common bacterial pathogen in veterinary medicine. Until now, limited cases of S. acidominimus have been reported in humans, in pneumonia [2, 3], pericarditis [4], meningitis, otitis median [5] and brain abscess [6]. Because of the poor recognition of its clinical significance in humans, identification of S. acidominimus as the causative species from the heterogeneous VGS has seldom been performed. Here, we report five cases of invasive diseases in a Han Chinese population caused by S. acidominimus over a one-year time frame.

Case presentation

Case 1

Our patient was a 67-year-old woman who came in for an elective operation of laparoscopic cholecystectomy. Two weeks previously, she had been diagnosed with choledocholithiasis and acute cholecystitis. Sonography and computed tomography confirmed the diagnosis. She received an emergency endoscopic retrograde cholangiopancreatography with insertion of a plastic stent (8.5F × 8.0cm) and antibiotics treatment. After that, her symptoms relieved gradually.

Her cholecystectomy was successful and after the operation she was treated with intravenous cefmetazole sodium (2g,bid). However, she then developed a continuous fever. Abdominal computed tomography one week after the surgery showed accumulated fluid in her gallbladder fossa. A catheter was used to drain the fluid and the purulent drainage material was sent for culture and cytology analysis. It grew S. acidominimus, identified through the Gram-positive cocci and presence of alpha hemolysis. Based on an antibiotics sensitivity test, levofloxacin (2.4g, qid) was started intravenously (Table 1). A pathology analysis revealed Rokitansky-Aschoff sinuses with chronic cholecystitis and choledocholithiasis. Our patient was discharged uneventfully 10 days later. A follow-up visit at four weeks revealed no infection.
Table 1

Antimicrobial susceptibility of Streptococcus acidominimus for the patients in our case series

Antibiotic or antibiotic class

Case 1

Case 2

Case 3

Case 4a

Case 5

Penicillin, ampicillin, and first-, second- and third-generation cephalosporins

S

S

R

R

S

Fluoroquinolones

S

S

S

S

S

Tetracycline

S

S

S

S

S

Clindamycin

R

R

R

R

R

Vancomycin

S

S

S

S

S

Linezolid

S

S

S

S

S

Azithromycin

S

S

S

R

R

aThis patient had a mixed infection of Enterococcus faecalis. The susceptibility results for E. faecalis showed resistance to gentamycin and penicillin, but sensitivity to vancomycin, linezolid and fluoroquinolones. S, sensitivity; R, resistance.

Case 2

A 60-year-old man underwent a chest laparoscopic esophageal resection, gastroesophageal anastomosis and jejunostomy under general anesthesia in our hospital because of esophageal squamous cell carcinoma. The operation was uneventful. After the operation, he had persistent fever. A blood test on the third postoperative day showed a white blood cell count of 15,800 cells/μL with 90.2% neutrophils. There was purulent drainage material, which showed Gram-positive cocci with alpha hemolysis. A culture grew S. acidominimus. Intravenous amoxicillin-sulbactam (3g, twice daily) was started for seven days (Table 1). He recovered and was discharged one month later. No recurrent infection was identified at a four-week follow-up visit.

Case 3

A 63-year-old woman received a liver transplant after receiving a diagnosis of liver cancer one and a half years’ previously. A pathology analysis revealed cholangiocarcinoma of her whole liver, with tumor thrombus and a large area of tissue necrosis in the right branch of her hepatic portal vein. After the operation, our patient presented with continuous fever. A blood test showed normal liver and kidney functions and hepatitis virus markers were all negative. Results of a coagulation test were within the normal range. At six weeks post-operation, her white blood cell count increased to 16,200 cells/μL with 80.2% neutrophils. A chest X-ray and upper abdominal computed tomography showed a subphrenic abscess and segmental lung atelectasis. After surgical drainage, the purulent material was sent for culture, which grew S. acidominimus. Our patient received levofloxacin (2.4g, qid) for six days (Table 1). She recovered and was discharged at eight weeks post-operation. No recurrent infection was present at a four-week follow-up visit.

Case 4

A 52-year-old man was admitted to our hospital because of hematuria and proteinuria of one month’s duration. He had a long history of hepatitis and decompensated liver cirrhosis with recurrent esophageal and gastric visceral bleeding. A blood test showed moderate anemia. Urine analysis showed protein, red blood cells, and a 24-hour protein measurement of 0.74g to 1.71g. His erythrocyte sedimentation rate and liver and kidney functions were all within normal ranges. He was diagnosed with hepatitis-related glomerulonephritis. Forty-eight hours after his admission, he presented with high fever, abdominal pain and vomiting. A physical examination showed abdominal tenderness and guarding, and decreased intestinal sound. An abdominal X-ray showed incomplete intestinal obstruction. A blood sample was immediately sent for culture and grew S. acidominimus. According to a susceptibility test, vancomycin (0.5g, bid) and levofloxacin (0.2g, bid) were initiated. One week later, he had made an uneventful clinical recovery, and was discharged after nine days of hospitalization. Follow-up at four weeks showed no recurrent infection.

Case 5

A 55-year-old woman was transferred to our hospital because of constant fever for one month’s duration. She had been under maintenance of hemodialysis for five years due to adult polycystic kidney disease and chronic renal failure. She had moderate anemia. On admission her white blood cell count was 9000 cells/μL with 74.5% neutrophils. A chest X-ray showed nothing of note. A blood culture was performed immediately after admission. It revealed a mixed infection of S. acidominimus with Enterococcus faecalis using a BD PhoenixSpec™ Calibrator Kit analysis (Becton, Dickinson and Company, Arizona, USA).

According to a susceptibility test, she was treated with vancomycin (0.5g, four times a day) and cefminox (1g, twice a day) for seven days. Her temperature returned to normal. She was discharged after 10 days of hospitalization. A follow-up at six weeks showed no recurrent infection.

Discussion

S. acidominimus is a member of VGS. Previously, the precise species of VGS has not routinely been identified. To the best of our knowledge, to date there have only been seven cases of S. acidominimus reported in humans (Table 2). With the advent of automated identification systems, it has become much easier to identify VGS to the species level. In the current observational study, we report five cases of infection caused by S. acidominimus in a Chinese population, which clearly merits special attention.
Table 2

Summary of cases with invasive Streptococcus acidominimus

Reference

Year

Country

Gender

Age

Community acquired

Specimen

Mixed infection

Underlying conditions

Infection loci

[3]

1988

Japan

M

41

Yes

Cerebral spinal fluid

No

None

Pneumonia, pericarditis

[4]

2003

USA

M

15

Yes

Blood

No

Ventricular septal defect

Pneumonia, pericarditis

[5]

2003

Israel

M

12

Yes

Pus drainage

No

None

Otitis media (Gradenigo’s syndrome)

[7]

2004

China

M

34

Yes

Pus drainage

No

Ovarian cyst

Abdominal encapsulated effusion

[2]

2008

USA

M

55

Yes

Pleural effusion

No

Hypertension, paranoid schizophrenia

Thoracic cavity

[6]

2007

USA

M

60

Yes

Pus drainage

No

None

Brain abscess

[8]

2008

USA

F

80

Yes

Blood

No

Aortic valve replacement, diabetes mellitus, hypertension, coronary artery disease

Prosthetic valve endocarditis

M

76

Yes

Blood

No

Non-small cell lung cancer, hypertension, coronary artery disease

Pneumonia

Present study

2011 to 2012

China

F

67

No

Pus drainage

No

Acute cholecystitis, post- endoscopic retrograde biliary drainage

Gallbladder fossa

M

60

No

Pus drainage

No

Esophageal cancer, post operation

Peritonitis

F

63

No

Pus drainage

No

Liver cancer, liver transplantation

Encapsulated pleural effusion

Fa

55

Unknown

Blood

Yes

Maintenance hemodialysis

Sepsis with no focus

M

52

No

Blood

No

Liver cirrhosis and hepatitis-related glomerulonephritis

Sepsis with incomplete intestinal obstruction

aThe infectious environment for this patient was undetermined because she was infected before admission, but she had long-term maintenance hemolysis. The mixed microorganism for her was Enterococcus faecalis. F, female; M, male.

None of our five patients had a history of pet or animal exposure or work exposure to animals or cattle. The current five cases had some clinical characteristics that were distinct from the previously reported seven cases of S. acidominimus (Table 2). The previous seven patients acquired the S. acidominimus in a community environment. Their age ranged from 12 to 80 years. Three of them (42.8%) were previously in excellent health. And no mixed infection was observed. In our five cases, the average age was 59.4 years (from 52 to 67). All had severe underlying diseases, and four of them had nosocomial infections (post-surgery). One patient was distinct in that she was on long-term maintenance hemodialysis, and developed sepsis with an undetermined infectious locus. She also had a mixed infection with E. faecalis. These data therefore suggest that S. acidominimus is causing increasingly nosocomial invasive diseases, especially in patients with severe underlying diseases.

There was also a great difference in the antimicrobial susceptibility test (Table 1). S. acidominimus has generally been believed to be sensitive to beta-lactam [9], as observed in the previous seven cases. However, in our five cases, there was increased resistance to beta-lactams, with two out of five being resistant. Additionally, compared to the zero resistance to macrolides in the previous cases, one of our patients was resistant. Further, the organisms in all five patients were resistant to clindamycin. The resistance of S. acidominimus to antibiotics warrants the accurate identification of the responsible species from the VGS to allow appropriate antibiotic treatment.

Finally, our patient on hemodialysis had a mixed infection of S. acidominimus and E. faecalis, a Gram-positive bacterium and member of the Lancefield group D streptococci [10]. Currently, E. faecalis is considered the second to third most common organism responsible for bacteremia in patients on chronic hemodialysis [11, 12]. The infection of S. acidominimus mixed with E. faecalis was especially resistant to multiple antibiotics including beta-lactams, macrolides, and clindamycin. We were unable to find any reported cases of S. acidominimus infection in a patient on hemodialysis. Therefore, to the best of our knowledge, our study represents the first such report and highlights the possibility of increased resistance in the case of a mixed infection.

Conclusions

S. acidominimus is an ever-increasing cause of disease, especially in patients who are critically ill. It is showing increased resistance to antimicrobial agents, so in patients with VGS infections, it is necessary to identify the species to improve the clinical management of S. acidominimus.

Consent

Written informed consent was obtained from the patients for publication of this manuscript. A copy of the written consent is available for review by the Editor-in-Chief of this journal.

Notes

Abbreviations

VGS: 

Viridans group streptococci.

Declarations

Acknowledgement

This work was supported by the General Program (Key Program, Major Research Plan) of National Natural Science Foundation of China (81230007) and National Natural Science Foundation of China (81200147, 81200185).

Authors’ Affiliations

(1)
Shanghai Institute of Cardiovascular Diseases, Zhongshan Hospital, Fudan University
(2)
Institute of Biomedical Science, Fudan University
(3)
Department of Clinical Laboratory, Zhongshan Hospital, Fudan University

References

  1. Siegman-Igra Y, Azmon Y, Schwartz D: Milleri group streptococcus–a stepchild in the viridans family. Eur J Clin Microbiol. 2012, 3: 2453-2459.View ArticleGoogle Scholar
  2. Baker L, Carlson R: Streptococcus acidominimus isolated from a multiloculated empyema in a critically ill adult man with pneumonia: case report and review of literature. Heart Lung. 2008, 37: 308-310. 10.1016/j.hrtlng.2007.08.002.View ArticlePubMedGoogle Scholar
  3. Akaike T, Suga M, Ando M, Ando Y, Araki S, Fujise R: Streptococcus acidominimus infections in a human. Jpn J Med. 1988, 27: 317-320. 10.2169/internalmedicine1962.27.317.View ArticlePubMedGoogle Scholar
  4. Brachlow A, Awadallah S, Chatterjee A: Endocarditis due to Streptococcus acidominimus. Pediatr Cardiol. 2003, 24: 161-163. 10.1007/s00246-002-0253-x.View ArticlePubMedGoogle Scholar
  5. Finkelstein Y, Marcus N, Mosseri R, Bar-Sever Z, Garty BZ: Streptococcus acidominimus infection in a child causing Gradenigo syndrome. Int J Pediatr Otorhi. 2003, 67: 815-817. 10.1016/S0165-5876(03)00088-0.View ArticleGoogle Scholar
  6. Cone LA, Etebar S, Waterbor RB: Brain abscess due to Streptococcus acidominimus: first case report. Surg Neurol. 2007, 67: 296-297. 10.1016/j.surneu.2006.06.062.View ArticlePubMedGoogle Scholar
  7. Zhang GL, Qiang QJ: Massive ascites due to Streptococcus acidominimus: report of one case. J First Mil Med Univ. 2004, 24: 545-Google Scholar
  8. Dalal A, Urban C: Human Infections Due to Streptococcus acidominimus. Infect Dis Clin Pract. 2008, 16: 283-284. 10.1097/IPC.0b013e31816fd608.View ArticleGoogle Scholar
  9. Maeda Y, Coulter WA, Goldsmith CE, Cherie Millar B, Moore JE: UV-C-irradiation sublethal stress does not alter antibiotic susceptibility of the viridans group streptococci to beta-lactam, macrolide, and fluoroquinolone antibiotic agents. J Investig Clin Dent. 2012, 3: 198-202. 10.1111/j.2041-1626.2011.00100.x.View ArticlePubMedGoogle Scholar
  10. Reffuveille F, Leneveu C, Chevalier S, Auffray Y, Rince A: Lipoproteins of Enterococcus faecalis: bioinformatic identification, expression analysis and relation to virulence. Microbiology. 2011, 157: 3001-3013. 10.1099/mic.0.053314-0.View ArticlePubMedGoogle Scholar
  11. Snyder GM, D’Agata EM: Novel antimicrobial-resistant bacteria among patients requiring chronic hemodialysis. Curr Opin Nephrol Hypertens. 2012, 21: 211-215. 10.1097/MNH.0b013e328350089b.View ArticlePubMedGoogle Scholar
  12. Li PK, Chow KM: Infectious complications in dialysis–epidemiology and outcomes. Nat Rev Nephrol. 2012, 8: 77-88.View ArticleGoogle Scholar

Copyright

© Wu et al.; licensee BioMed Central Ltd. 2014

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.